Printer Friendly

DU PONT MERCK NAMES HORNER MANAGING DIRECTOR FOR U.K.

 DU PONT MERCK NAMES HORNER MANAGING DIRECTOR FOR U.K.
 WILMINGTON, Del., Jan. 14 /PRNewswire/ -- The Du Pont Merck


Pharmaceutical Company has named Ann Horner managing director of its Du Pont Pharmaceuticals U.K. subsidiary.
 Horner, a native of Washington, had previously been secretary to the Management Committee of the Wilmington-based drug company. Prior to that, she had been a group product manager.
 Du Pont Pharmaceuticals U.K. is headquartered in Letchworth, England. Horner and her family reside in Hertfordshire, England.
 Horner graduated from Washington College in 1980 with a bachelor's degree in biology and received a master's of business administration in 1985 from Wilmington College.
 Du Pont Merck, which began operations on Jan. 1, 1991, is an independent worldwide pharmaceutical company established by Du Pont (NYSE: DD) and Merck & Co., Inc. (NYSE: MRK). With R&D expenditures exceeding $230 million annually, it is a research-based company focused on therapeutics for cardiovascular and central nervous system diseases, oncology, inflammatory and viral diseases, and on radiopharmaceuticals. Du Pont Merck, headquartered in Wilmington, expects to report first-year sales of $700 million.
 /delval/
 -0- 1/14/92
 /CONTACT: Roger R. Morris of Du Pont Merck, 302-992-4747/
 (DDD MRK) CO: Du Pont Merck Pharmaceutical Company ST: Delaware IN: MTC SU: PER


JS -- PH026 -- 9642 01/14/92 15:00 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jan 14, 1992
Words:216
Previous Article:SOUTHERN NATURAL GAS COMPANY OFFERS $100 MILLION OF 7.85 PERCENT NOTES DUE JAN. 15, 2002
Next Article:AT&T OFFERS GEORGIA RESIDENTS REDUCED LONG DISTANCE PRICES ON MARTIN LUTHER KING DAY
Topics:


Related Articles
DU PONT MERCK NAMES ARNER ASSISTANT GENERAL COUNSEL
DU PONT MERCK CEO RECEIVES HONORARY DOCTORATE
DU PONT MERCK NAMES FLETCHER AS GOVERNMENT AFFAIRS MANAGER
DU PONT MERCK NAMES BLANK VP FOR WORLDWIDE MARKETING
DU PONT MERCK HONORS OUTSTANDING SALES ACHIEVEMENTS: DISTRICT OF THE YEAR AWARDS
ANTONIO J. GRILLO-LOPEZ JOINS IDEC PHARMACEUTICALS AS VICE PRESIDENT, MEDICAL AND REGULATORY AFFAIRS
ANTONIO J. GRILLO-LOPEZ JOINS IDEC PHARMACEUTICALS AS VICE PRESIDENT, MEDICAL AND REGULATORY AFFAIRS
DU PONT MERCK ANNOUNCES PERSONNEL APPOINTMENT
MEDCO RESEARCH NAMES DIRECTOR, RADIOPHARMACEUTICAL CLINICAL RESEARCH
DU PONT MERCK EXECUTIVE JOINS SYMPHONY PHARMACEUTICALS

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters